Fertility Fears – Fate of the Fat
Abstract
It is well known that being overweight or clinically obese can have adverse effects on health. In the past, little was known about the impact of obesity on male reproductive function. However, several recent studies clearly show that obesity is associated with reduced semen quality and erectile dysfunction, and therefore obesity can be regarded as a cause of male infertility. It is believed that excess fat leads to changes in hormone levels (e.g. adipocytes increase aromatisation of testosterone to oestrogen) as well as dysregulation of the hypothalamus–pituitary–gonadal axis. Higher levels of adipose-derived hormones and adipokines combined with physical disorders can further contribute to obesity-induced infertility. Several treatment options, e.g. lifestyle changes, pharmacological interventions and surgical options, are being explored for their ability to restore fertility in the obese. Urologists and fertility specialists must be more aware of the role obesity plays in the aetiology of male infertility.Obesity, male infertility, reproductive hormones, adipose-derived hormones, adipokines, sperm parameters, body mass index
Evidence suggests that male fertility is decreasing not only in westernised societies but worldwide. This is evident from various population-based studies as well as from the increasing numbers of couples seeking infertility treatment.1–4 As yet, questions remain as to the cause of these findings. Several reports have focused on the possible link between obesity and male infertility.4–8 It is speculated that obesity disrupts male reproduction by impairing semen parameters and reducing secondary sex characteristics.9 It is thus of importance for urologists and fertility physicians to assess male body composition during the normal fertility work-up and to focus on obesity as an aetiology of male infertility.
Obesity – Definition and Prevalence
Obesity is a medical condition in which excess body fat, or white adipose tissue, accumulates in the body.9 Overweight and obesity are more broadly defined as abnormal or excessive fat accumulation that may impair health.
Only a few methods can accurately measure fat content, including underwater weighing and dual-energy X-ray absorptiometry (DEXA), but these methods are not practical and are performed only in research centres with specialised equipment. Therefore, the most commonly used method is the most simple to perform: body mass index (BMI), which is defined as weight in kilograms divided by the square of the height in metres (kg/m2). A BMI >25kg/m2 is considered overweight and a BMI >30kg/m2 is considered to be obese. Waist circumference and the waist-to-hip ratio (WHR) are less commonly used to diagnose obesity. In fact, they may be more accurate in predicting obesity-related health issues. For males, a waist circumference of 102cm or greater is considered to be unhealthy, while a WHR <0.9 is considered normal.10–12 Other anthropometrical measurements such as skin fold thickness, bioelectrical impedance analysis, risk factors and co-morbidities are also used to diagnose obesity.
Sedentary lifestyles and decreased physical activity combined with an increased intake of energy-dense foods high in fat and sugars lead to an energy imbalance whereby energy consumed exceeds energy expended.9 This lifestyle is the key cause of the global increase in overweight and obesity and the reason it is reaching epidemic proportions in several countries. In the US alone, more than 35–40% of the population is believed to have a BMI >30kg/m2.13,14 Once considered to be a problem only of westernised countries, this phenomenon is now dramatically on the increase in developing countries and, specifically, in young children (six to nine years of age).15 The global prevalence of obesity has doubled in the past decade, and at this rate it is predicted that almost one billion people will suffer from obesity in the next five years.15
- Carlsen E, Giwercman A, Keiding N, Skakkebaek NE, Evidence for decreasing quality of semen during past 50 years, Br Med J, 1992;305(6854):609–13.
- Irvine S, Cawood E, Richardson D, et al., Evidence of deteriorating semen quality in the United Kingdom: birth cohort study in 577 men in Scotland over 11 years, Br Med J, 1996;312(7029):467–71.
- van Waeleghem K, De Clercq N, Vermeulen L, et al., Deterioration of sperm quality in young healthy Belgian men, Hum Reprod, 1996;11(2):325–9.
- Swan SH, Elkin EP, Fenster L, The question of declining sperm density revisited: an analysis of 101 studies published 1934–1996, Environ Health Perspect, 2000;108(10):961–6.
- Martini AC, Tissera A, Estofan D, et al., Overweight and seminal quality: a study of 794 patients, Fertil Steril, 2010 (Epub ahead of print).
- Hammoud AO, Gibson M, Peterson CM, et al., Impact of male obesity on infertility: a critical review of the current literature, Fertil Steril, 2008;90(4):897–904.
- Hedley AA, Ogden CL, Johnson CL, et al., Prevalence of overweight and obesity among US children, adolescents, and adults, 1999–2002, JAMA, 2004;291(23):2847–50.
- Mokdad AH, Serdula MK, Dietz WH, et al., The spread of the obesity epidemic in the United States, 1991–1998, JAMA, 1999;282(16):1519–22.
- Du Plessis SS, Cabler S, McAlister DA, et al., The effect of obesity on sperm disorders and male infertility, Nat Rev Urol, 2010;7:153–61.
- Booth ML, Hunter C, Gore CJ, et al., The relationship between body mass index and waist circumference: implications for estimates of the population prevalence of overweight, Int J Obes Relat Metab Disord, 2000;24(8): 1058–61.
- Huxley R, Mendis S, Zheleznyakov E, et al., Body mass index, waist circumference and waist:hip ratio as predictors of cardiovascular risk—a review of the literature, Eur J Clin Nutr, 64(1):16–22.
- Akpinar E, Bashan I, Bozdemir N, Saatci E, Which is the best anthropometric technique to identify obesity: body mass index, waist circumference or waist-hip ratio?, Coll Antropol, 2007;31(2):387–93.
- Isidori AM, Caprio M, Strollo F, et al., Leptin and androgens in male obesity: evidence for leptin contribution to reduced androgen levels, J Clin Endocrinol Metab, 1999;84(10):3673–80.
- WHO, Prevalence of overweight, obesity and extreme obesity among adults: United States, trends 1976–80 through 2005–2006, 2006. Available at: apps.who.int/infobase/reportviewer.aspx?rptcode=ALL& uncode=840&dm=5&surveycode=102913a1
- Popkin BM, Recent dynamics suggest selected countries catching up to US obesity, Am J Clin Nutr, 91(1):284S–8S.
- Fedorcsak P, Dale PO, Storeng R, et al., Impact of overweight and underweight on assisted reproduction treatment, Hum Reprod, 2004;19(11):2523–8.
- Pasquali R, Pelusi C, Genghini S, et al., Obesity and reproductive disorders in women, Hum Reprod Update, 2003;9(4):359–72.
- Sallmen M, Sandler DP, Hoppin JA, et al., Reduced fertility among overweight and obese men, Epidemiology, 2006;17(5):520–23.
- Nguyen RH, Wilcox AJ, Skjaerven R, Baird DD, Men’s body mass index and infertility, Hum Reprod, 2007;22(9):2488–93.
- Ramlau-Hansen CH, Thulstrup AM, Nohr EA, et al., Subfecundity in overweight and obese couples, Hum Reprod, 2007;22(6):1634–7.
- Jensen TK, Andersson AM, Jorgensen N, et al., Body mass index in relation to semen quality and reproductive hormones among 1,558 Danish men, Fertil Steril, 2004;82(4):863–70.
- Strain GW, Zumoff B, Kream J, et al., Mild hypogonadotropic hypogonadism in obese men, Metabolism, 1982;31(9):871–5.
- Pauli EM, Legro RS, Demers LM, et al., Diminished paternity and gonadal function with increasing obesity in men, Fertil Steril, 2008;90(2):346–51.
- Hammoud AO, Wilde N, Gibson M, et al., Male obesity and alteration in sperm parameters, Fertil Steril, 2008;90(6):2222–5.
- Smit M, Romijn JC, Wildhagen MF, et al., Sperm chromatin structure is associated with the quality of spermatogenesis in infertile patients, Fertil Steril, 2009 (Epub ahead of print).
- Kort HI, Massey JB, Elsner CW, et al., Impact of body mass index values on sperm quantity and quality, J Androl, 2006;27(3):450–52.
- Evenson D, Wixon R, Meta-analysis of sperm DNA fragmentation using the sperm chromatin structure assay, Reprod Biomed Online, 2006;12(4):466–72.
- Traish AM, Feeley RJ, Guay A, Mechanisms of obesity and related pathologies: androgen deficiency and endothelial dysfunction may be the link between obesity and erectile dysfunction, FEBS J, 2009;276(20):5755–67.
- Cheng JY, Ng EM, Body mass index, physical activity and erectile dysfunction: an U-shaped relationship from population-based study, Int J Obes (Lond), 2007;31(10): 1571–8.
- Corona G, Mannucci E, Schulman C, et al., Psychobiologic correlates of the metabolic syndrome and associated sexual dysfunction, Eur Urol, 2006;50(3):595–604, discussion 604.
- Athyros VG, Tziomalos K, Karagiannis A, et al., Should adipokines be considered in the choice of the treatment of obesity-related health problems?, Curr Drug Targets, 2010;11(1):122–35.
- Trayhurn P, Beattie JH, Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ, Proc Nutr Soc, 2001;60(3):329–39.
- Bhat GK, Sea TL, Olatinwo MO, et al., Influence of a leptin deficiency on testicular morphology, germ cell apoptosis, and expression levels of apoptosis-related genes in the mouse, J Androl, 2006;27(2):302–10.
- Jope T, Lammert A, Kratzsch J, et al., Leptin and leptin receptor in human seminal plasma and in human spermatozoa, Int J Androl, 2003;26(6):335–41.
- Bener A, Al-Ansari AA, Zirie M, Al-Hamaq AO, Is male fertility associated with type 2 diabetes mellitus?, Int Urol Nephrol, 2009;41(4):777–84.
- Agbaje IM, Rogers DA, McVicar CM, et al., Insulin dependant diabetes mellitus: implications for male reproductive function, Hum Reprod, 2007;22(7):1871–7.
- Lima N, Cavaliere H, Knobel M, et al., Decreased androgen levels in massively obese men may be associated with impaired function of the gonadostat, Int J Obes Relat Metab Disord, 2000;24(11):1433–7.
- Roth MY, Amory JK, Page ST, Treatment of male infertility secondary to morbid obesity, Nat Clin Pract Endocrinol Metab, 2008;4(7):415–19.
- Giagulli VA, Kaufman JM, Vermeulen A, Pathogenesis of the decreased androgen levels in obese men, J Clin Endocrinol Metab, 1994;79(4):997–1000.
- Tchernof A, Despres JP, Belanger A, et al., Reduced testosterone and adrenal C19 steroid levels in obese men, Metabolism, 1995;44(4):513–19.
- Kumanov P, Nandipati K, Tomova A, Agarwal A, Inhibin B is a better marker of spermatogenesis than other hormones in the evaluation of male factor infertility, Fertil Steril, 2006;86(2):332–8.
- Globerman H, Shen-Orr Z, Karnieli E, et al., Inhibin B in men with severe obesity and after weight reduction following gastroplasty, Endocr Res, 2005;31(1):17–26.
- Fraczek M, Kurpisz M, Inflammatory mediators exert toxic effects of oxidative stress on human spermatozoa, J Androl, 2007;28(2):325–33.
- Lampiao F, du Plessis SS, TNF-alpha and IL-6 affect human sperm function by elevating nitric oxide production, Reprod Biomed Online, 2008;17(5):628–31.
- Agarwal A, Sharma RK, Nallella KP, et al., Reactive oxygen species as an independent marker of male factor infertility, Fertil Steril, 2006;86(4):878–85.
- Vgontzas AN, Papanicolaou DA, Bixler EO, et al., Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia, J Clin Endocrinol Metab, 2000;85(3):1151–8.
- Luboshitzky R, Lavie L, Shen-Orr Z, Herer P, Altered luteinizing hormone and testosterone secretion in middle-aged obese men with obstructive sleep apnea, Obes Res, 2005;13(4):780–86.
- Hjollund NH, Bonde JP, Jensen TK, Olsen J, Diurnal scrotal skin temperature and semen quality. The Danish First Pregnancy Planner Study Team, Int J Androl, 2000;23(5):309–18.
- Feeley RJ, Traish AM, Obesity and erectile dysfunction: is androgen deficiency the common link?, Scientific World J, 2009;9:676–84.
- Diaz-Arjonilla M, Schwarcz M, Swerdloff RS, Wang C, Obesity, low testosterone levels and erectile dysfunction, Int J Impot Res, 2009;21(2):89–98.
- Suzuki Y, Sasagawa I, Tateno T, et al., Absence of microdeletions in the Y chromosome in patients with Prader-Willi syndrome with cryptorchidism, Int J Androl, 2002;25(1):1–5.
- Arsov T, Silva DG, O’Bryan MK, et al., Fat aussie—a new Alstrom syndrome mouse showing a critical role for ALMS1 in obesity, diabetes, and spermatogenesis, Mol Endocrinol, 2006;20(7):1610–22.
- Farooqi IS, Wangensteen T, Collins S, et al., Clinical and molecular genetic spectrum of congenital deficiency of the leptin receptor, N Engl J Med, 2007;356(3):237–47.
- Okada Y, Tateishi K, Zhang Y, Histone demethylase JHDm2A is involved in male infertility and obesity, J Androl, 2010;31(1):75–8.
- Kasturi SS, Tannir J, Brannigan RE, The metabolic syndrome and male infertility, J Androl, 2008;29(3):251–9.
- Chavarro JE, Toth TL, Wright DL, et al., Body mass index in relation to semen quality, sperm DNA integrity, and serum reproductive hormone levels among men attending an infertility clinic, Fertil Steril, 2010;93(7):2222–31.
- Kaukua J, Pekkarinen T, Sane T, Mustajoki P, Sex hormones and sexual function in obese men losing weight, Obes Res, 2003;11(6):689–94.
- Niskanen L, Laaksonen DE, Punnonen K, et al., Changes in sex hormone-binding globulin and testosterone during weight loss and weight maintenance in abdominally obese men with the metabolic syndrome, Diabetes Obes Metab, 2004;6(3):208–15.
- Sharman MJ, Volek JS, Weight loss leads to reductions in inflammatory biomarkers after a very-low-carbohydrate diet and a low-fat diet in overweight men, Clin Sci (Lond), 2004;107(4):365–9.
- Ziccardi P, Nappo F, Giugliano G, et al., Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year, Circulation, 2002;105(7):804–9.
- Prescription Medication for the Treatment of Obesity. 2007. Available at: win.niddk.nih.gov/publications/ prescription.htm
- Encinosa WE, Bernard DM, Chen CC, Steiner CA, Healthcare utilization and outcomes after bariatric surgery, Med Care, 2006;44(8):706–12.
- Bastounis EA, Karayiannakis AJ, Syrigos K, et al., Sex hormone changes in morbidly obese patients after vertical banded gastroplasty, Eur Surg Res, 1998;30(1):43–7.
- di Frega AS, Dale B, Di Matteo L, Wilding M, Secondary male factor infertility after Roux-en-Y gastric bypass for morbid obesity: case report, Hum Reprod, 2005;20(4):997–8.
- Zumoff B, Miller LK, Strain GW, Reversal of the hypogonadotropic hypogonadism of obese men by administration of the aromatase inhibitor testolactone, Metabolism, 2003;52(9):1126–8.
- Hatzimouratidis K, Amar E, Eardley I, et al., Guidelines on Male Sexual Dysfunction: Erectile Dysfunction and Premature Ejaculation, Eur Urol, 2010 (Epub ahead of print).
- Heidelbaugh JJ, Management of erectile dysfunction, Am Fam Physician, 81(3):305–12.
- Awartani KA, Nahas S, Al Hassan SH, et al., Infertility treatment outcome in sub groups of obese population, Reprod Biol Endocrinol, 2009;7:52.
- Hammoud AO, Gibson M, Peterson CM, et al., Obesity and male reproductive potential, J Androl, 2006;27(5): 619–26.










